Front Row Advisors LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
Front Row Advisors LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$7,116
+101557.1%
4600.0%0.00%0.0%
Q2 2023$7
-12.5%
4600.0%0.00%
-25.0%
Q1 2023$8
+60.0%
460
+46.0%
0.00%
+33.3%
Q4 2022$5
-99.9%
315
-31.5%
0.00%0.0%
Q3 2022$6,0000.0%4600.0%0.00%0.0%
Q2 2022$6,000
-14.3%
4600.0%0.00%0.0%
Q1 2022$7,000
+16.7%
4600.0%0.00%
+50.0%
Q4 2021$6,000
-25.0%
4600.0%0.00%
-33.3%
Q3 2021$8,0000.0%4600.0%0.00%0.0%
Q2 2021$8,000
-63.6%
460
-62.5%
0.00%
-72.7%
Q1 2021$22,0000.0%1,2270.0%0.01%0.0%
Q4 2020$22,0000.0%1,2270.0%0.01%
-8.3%
Q3 2020$22,000
-15.4%
1,227
-13.8%
0.01%
-25.0%
Q2 2020$26,0000.0%1,4230.0%0.02%
-11.1%
Q1 2020$26,000
+4.0%
1,423
+10.4%
0.02%
+12.5%
Q4 2019$25,000
+13.6%
1,2890.0%0.02%0.0%
Q3 2019$22,000
-8.3%
1,289
-3.3%
0.02%
-5.9%
Q2 2019$24,000
+9.1%
1,333
+23.7%
0.02%0.0%
Q1 2019$22,0001,0780.02%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders